Brian Neville serves as Chief Accounting Officer at Core Scientific, responsible for all controllership functions, revenue and financial reporting, business process and systems improvement, technology tools, enterprise systems, and treasury management.
Prior to Core Scientific, Neville spent six years at PATH as Controller and later Chief Accounting Officer, where he led a multi-year finance process overhaul and implementation of a cloud-based global ERP system (Unit 4's Business World) completed in April 2018. Before PATH, he was Senior Vice President and Corporate Controller at HomeStreet, Inc. and held leadership finance roles at T-Mobile, JP Morgan Chase, Washington Mutual, and Clark Nuber, a Bellevue-based public accounting firm.
Neville holds a Bachelor of Arts in Business/Accounting and Information Systems from the University of Washington and is a licensed CPA.
Biography extracted from Core Scientific — https://investors.corescientific.com/investors/governance/executive-officers/default.aspx (archived 2022-05-17) View cached copy (2026-09-27)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Chief Accounting Officer | 2022-01 → present (4y 10mo) | 4 |
Show 4 underlying filings | |||
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 480,044 | $0 | 29,890 | $59.7K | ↓ Divested $59.7K | 4 | $6.36M | $396.0K |
| 2022 | 480,044 | $0 | 29,890 | $59.7K | ↓ Divested $59.7K | 4 | $6.36M | $396.0K |
| 2022-Q2 | 480,044 | $0 | 27,454 | $55.6K | ↓ Divested $55.6K | 3 | $6.36M | $363.8K |
| 2022-Q3 | - | $0 | 2,436 | $4.0K | ↓ Divested $4.0K | 1 | $0 | $32.3K |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-10-30); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2022-09-19 | Core Scientific | Tax withholding on vesting | 2,436 | $4,044 | $32.3K |
| 2022-06-24 | Core Scientific | Tax withholding on vesting | 2,436 | $5,091 | $32.3K |
| 2022-06-13 | Core Scientific | Grant / award / vesting | 480,044 | - | $6.36M |
| 2022-06-13 | Core Scientific | Tax withholding on vesting | 25,018 | $50,536 | $331.5K |